Datamonitor's OTC Pharmaceuticals in Australia industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

Contains an executive summary and data on value, volume and/or segmentation
Provides textual analysis of OTC Pharmaceuticals in Australia's recent performance and future prospects
Incorporates in-depth five forces competitive environment analysis and scorecards
Includes a five-year forecast of OTC Pharmaceuticals in Australia
The leading companies are profiled with supporting key financial metrics
Supported by the key macroeconomic and demographic data affecting the market

Highlights

Detailed information is included on market size, measured by both value and volume
Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
Market shares are covered by manufacturer and/or brand
Also features market breakdown by distribution channel

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purposes of this report, Asia-Pacific comprises Australia, China, India, Japan, Singapore, South Korea, and Taiwan.

Executive Summary
Market Overview
- Market Definition
- Research Highlights
- Market Analysis
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Five Forces Analysis
- Summary
- Buyer Power
- Supplier Power
- New Entrants
- Substitutes
- Rivalry
Leading Companies
- Cerebos Pacific Limited
- Reckitt Benckiser Plc
- Johnson & Johnson
Market Distribution
Market Forecasts
- Market Value Forecast
Macroeconomic Indicators
Appendix
- Methodology
- Industry Associations
- Related Datamonitor Research
- Disclaimer
About Datamonitor
- Premium Reports
- Summary Reports
- Datamonitor Consulting
List of Tables
- Table 1: Australia Otc Pharmaceuticals Market Value: $ Million, 2005-09
- Table 2: Australia Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
- Table 3: Australia Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
- Table 4: Australia Otc Pharmaceuticals Market Share: % Share, by Value, 2009
- Table 5: Cerebos Pacific Limited: Key Facts
- Table 6: Cerebos Pacific Limited: Key Financials ($)
- Table 7: Cerebos Pacific Limited: Key Financials (Si$)
- Table 8: Cerebos Pacific Limited: Key Financial Ratios
- Table 9: Reckitt Benckiser Plc: Key Facts
- Table 10: Reckitt Benckiser Plc: Key Financials ($)
- Table 11: Reckitt Benckiser Plc: Key Financials (£)
- Table 12: Reckitt Benckiser Plc: Key Financial Ratios
- Table 13: Johnson & Johnson: Key Facts
- Table 14: Johnson & Johnson: Key Financials ($)
- Table 15: Johnson & Johnson: Key Financial Ratios
- Table 16: Australia Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
- Table 17: Australia Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14
- Table 18: Australia Size of Population (Million), 2005-09
- Table 19: Australia Gdp (Constant 2000 Prices, $ Billion), 2005-09
- Table 20: Australia Gdp (Current Prices, $ Billion), 2005-09
- Table 21: Australia Inflation, 2005-09
- Table 22: Australia Consumer Price Index (Absolute), 2005-09
- Table 23: Australia Exchange Rate, 2005-09
List of Figures
- Figure 1: Australia Otc Pharmaceuticals Market Value: $ Million, 2005-09
- Figure 2: Australia Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
- Figure 3: Australia Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
- Figure 4: Australia Otc Pharmaceuticals Market Share: % Share, by Value, 2009
- Figure 5: Forces Driving Competition in The Otc Pharmaceuticals Market in Australia, 2009
- Figure 6: Drivers of Buyer Power in The Otc Pharmaceuticals Market in Australia, 2009
- Figure 7: Drivers of Supplier Power in The Otc Pharmaceuticals Market in Australia, 2009
- Figure 8: Factors Influencing The Likelihood of New Entrants in The Otc Pharmaceuticals Market in Australia, 2009
- Figure 9: Factors Influencing The Threat of Substitutes in The Otc Pharmaceuticals Market in Australia, 2009
- Figure 10: Drivers of Degree of Rivalry in The Otc Pharmaceuticals Market in Australia, 2009
- Figure 11: Cerebos Pacific Limited: Revenues & Profitability
- Figure 12: Cerebos Pacific Limited: Assets & Liabilities
- Figure 13: Reckitt Benckiser Plc: Revenues & Profitability
- Figure 14: Reckitt Benckiser Plc: Assets & Liabilities
- Figure 15: Johnson & Johnson: Revenues & Profitability
- Figure 16: Johnson & Johnson: Assets & Liabilities
- Figure 17: Australia Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
- Figure 18: Australia Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14

Pharmaceutical Market Research

OTC Pharmaceuticals in Australia